INO — INOVIO PHARMACEUTICALS INC
As of Q2 2026, 16 SEC-registered investment managers reported holding INO (INOVIO PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $16.61M across 15.10M shares. That is -24.1% by share count (-4.80M shares) versus the previous quarter, while reported value moved -52.1%. Ownership is concentrated: the five largest holders account for 83.8% of reported value and the top ten for 98.5%.
Compared with the prior quarter, 2 opened new positions, 6 added to existing stakes, 6 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
INO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.45M | $9.30M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 3.31M | $5.77M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 3.32M | $5.77M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.35M | $1.49M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 1.24M | $1.36M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 802.75K | $883.75K | 0.00% | Hold |
| Millennium Management history | Q2 2026 | 796.11K | $875.72K | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 779.06K | $856.96K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 645.48K | $710.02K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 361.34K | $397.47K | 0.00% | Reduce |
| Wellington Management Group history | Q3 2024 | 65.63K | $379.36K | 0.00% | New |
| Balyasny Asset Management history | Q1 2024 | 22.25K | $308.77K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 262.32K | $288.55K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 174.39K | $191.83K | 0.00% | Reduce |
| BNY Mellon history | Q1 2025 | 75.42K | $122.94K | 0.00% | Add |
| Amundi US history | Q1 2024 | 11.61K | $118.38K | 0.00% | New |
| AQR Capital Management history | Q2 2025 | 53.17K | $108.20K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 93.72K | $103.09K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 80.34K | $88.37K | 0.00% | New |
| Manulife Financial history | Q2 2024 | 10.17K | $82.17K | 0.00% | New |
New Positions (Q2 2026)
- Invesco Ltd 80.34K sh · $88.37K
- JPMorgan Chase & Co 46 sh · $52
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 3.31M sh · $5.77M
- Bank of America Corp sold 32.68K sh · $56.86K
- Marshall Wace sold 13.19K sh · $22.95K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | 12.41K | 5.80K | 27.26K | 81.38K | 100.67K | 87.34K | 1.30K | 9.85M | 9.34M | 8.45M |
| D. E. Shaw & Co | 5.00M | 5.00M | 5.00M | 5.00M | 6.50M | 6.50M | 6.50M | 6.50M | 6.50M | 6.50M | — | — | — | — | — | — | 806.74K | 2.23M | 2.21M | 1.35M |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | 20.26K | 37.60K | 23.20K | — | 72.36K | 72.73K | 290.80K | 322.74K | 390.38K | 1.24M |
| Geode Capital Management | — | — | — | — | — | — | — | — | — | — | 252.60K | 582.80K | 621.63K | 628.50K | 846.80K | 437.55K | 546.75K | 769.36K | 801.50K | 802.75K |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | 267.80K | 25.77K | 30.22K | — | — | 346.87K | 1.97M | 1.40M | 1.41M | 796.11K |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 1.89M | 1.91M | 2.32M | 537.63K | 499.40K | 617.87K | 662.18K | 779.06K |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | — | 76.34K | 53.79K | 56.75K | 71.73K | 29.10K | 258.46K | 144.00K | 429.10K | 421.85K | 645.48K |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | 450.27K | 410.57K | 331.07K | 242.31K | 45.83K | 328.13K | 816.34K | 553.16K | 643.78K | 361.34K |
| UBS Group AG | — | — | — | — | — | — | — | — | — | — | 1.92K | 27.39K | 13.71K | 176.97K | 207.87K | 199.68K | 293.06K | 170.58K | 249.65K | 262.32K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | 49.05K | 61.11K | 205.79K | 219.06K | 465.78K | 254.43K | 238.47K | 299.98K | 298.87K | 174.39K |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | — | 42.40K | 73.19K | 290.44K | 130.53K | 136.77K | 53.71K | 27.29K | 44.72K | 93.72K |
| Invesco Ltd | — | — | — | — | — | — | — | — | — | — | — | 11.49K | 11.01K | 12.04K | 11.78K | — | — | — | — | 80.34K |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | — | 68.87K | 103.71K | 95.13K | 133.28K | 284.64K | 401.86K | 786.77K | 105.83K | 63.86K | 50.26K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | 1.50K | 13.12K | 13.45K | 16.69K | 22.37K | 967 | 216 | 2.74K | 2.87K | 3.26K |
| PNC Financial Services | — | — | — | — | — | — | — | — | — | — | 450 | 450 | 450 | 450 | 524 | 6.17K | 1.03K | 885 | 300 | 300 |
| JPMorgan Chase & Co | — | — | — | 255.00K | 255.00K | 255.00K | 255.00K | — | — | — | 473 | 11.30K | 11.75K | 11.94K | 17.63K | 3.69K | 65.21K | 42 | — | 46 |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | 37.56K | 38.36K | 56.47K | 640.99K | 1.30M | 1.27M | 636.06K | 65.79K | 32.68K | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | 35.18K | 5.71K | 18.93K | 20.02K | 25.04K | 14.62K | 12.98K | — | — | — |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | 51.98K | — | — | — | — | — | — | 82.33K | 13.19K | — |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | — | 11.07K | 71.10K | 71.07K | 71.07K | 98.50K | 12.01K | 12.33K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details